OSAM
CSCI

O'Shaughnessy Asset Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

O'Shaughnessy Asset Management’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-283
Closed -$29K – 1918
2019
Q3 		$29K Sell
283
-41
-13% -$8.88K ﹤0.01% 763
2019
Q2 		$96K Buy
324
+73
+29% +$25.7K ﹤0.01% 655
2019
Q1 		$116K Buy
251
+26
+12% +$10.1K ﹤0.01% 626
2018
Q4 		$66K Buy
+225
New +$53.8K ﹤0.01% 679

Other funds holding CSCI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

O'Shaughnessy Asset Management's CSCI Position: Q4 2019 in Review

O'Shaughnessy Asset Management sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q4 2019, closing a stake of 283 shares — an estimated $29K sold.

O'Shaughnessy Asset Management first reported a position in CSCI in Q4 2018 and held it in 4 quarters. The position peaked at $116K in Q1 2019. 24 funds tracked by Wall St. Rank hold CSCI as of Q4 2019.

  • O'Shaughnessy Asset Management reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 283 COSCIENS Biopharma Inc. Common Stock shares in Q4 2019, an estimated $29K.
  • O'Shaughnessy Asset Management first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2018 and held it in 4 quarters.
  • O'Shaughnessy Asset Management's COSCIENS Biopharma Inc. Common Stock position peaked at $116K in Q1 2019.
  • 24 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2019.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.